• 13 DE
• 14 EN

• 9 Home
• 10 Contact
• 11 Sitemap

• 7 Press
  • 7.1 Press Releases
    • 7.1.1 Company
      • 7.1.1.1 2000
      • 7.1.1.2 2009
      • 7.1.1.3 2010
      • 7.1.1.4 2001
      • 7.1.1.5 2002
      • 7.1.1.6 2003
      • 7.1.1.7 2004
      • 7.1.1.8 2005
      • 7.1.1.9 2006
      • 7.1.1.10 2007
      • 7.1.1.11 2008
    • 7.1.2 Health
  • 7.2 Photos & Logos

Press Releases Company 2007

• Merz Group experiences successful 2006/07 financial year (20 Nov 2007)

• The Expansion Continues: Merz Invests an Additional Million Euro Sum in Dessau (26 Jul 2007)

• Recommendation of Approval for the Merz Botulinum Neurotoxin Typ A in European Countries (20 Jul 2007)

• Merz Pharmaceuticals and Tel Aviv University Become Partners in Novel Drug Technology Development for Treatment of Alzheimer's (10 Jul 2007)

• Merz provides evidential proof of its success in tinnitus study – considerable expansion of the research & development department (05 Jul 2007)

• Merz funded Alois Alzheimer Award 2007 bestowed upon Professor Dr. Agneta Nordberg (15 Jun 2007)

• Merz bets on growth - Hans-Jörg Bergler takes over leadership of the newly created Corporate Development / Mergers & Acquisitions department (04 Jun 2007)

• Alzheimer's medication Memantine exceeds blockbuster mark of 1 billion US dollars (15 May 2007)

• "Change in Merz Group leadership: Professor Scheuble will be leaving the company (23 Apr 2007)

• Frankfurt Biotechnology Innovation Center plans large expansion with Merz Pharma (01 Feb 2007)

• 0.1 A-
• 0.2 A
• 0.3 A+
• 0.4 Print

Search

Search

Search

Login for Professionals

Login for Professionals

Merz DocCheck User Password

new user

German Websites

• Alzheimer´s
• Depression
• Dystonia
• Hair Loss
• Hyal-System
• Liver Disease
• Parkinson´s